Department of Pediatric Cardiology and Congenital Heart Disease, Charité University Medicine Berlin; Department of Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum Berlin.
Department of Pediatric Cardiology and Congenital Heart Disease, Charité University Medicine Berlin.
J Vis Exp. 2022 Jun 8(184). doi: 10.3791/63661.
Transcatheter pulmonary valve replacement has been established as a viable alternative approach for patients suffering from right ventricular outflow tract or bioprosthetic valve dysfunction, with excellent early and late clinical outcomes. However, clinical challenges such as stented heart valve deterioration, coronary occlusion, endocarditis, and other complications must be addressed for lifetime application, particularly in pediatric patients. To facilitate the development of a lifelong solution for patients, transcatheter autologous pulmonary valve replacement was performed in an adult sheep model. The autologous pericardium was harvested from the sheep via left anterolateral minithoracotomy under general anesthesia with ventilation. The pericardium was placed on a 3D shaping heart valve model for non-toxic cross-linking for 2 days and 21 h. Intracardiac echocardiography (ICE) and angiography were performed to assess the position, morphology, function, and dimensions of the native pulmonary valve (NPV). After trimming, the crosslinked pericardium was sewn onto a self-expandable Nitinol stent and crimped into a self-designed delivery system. The autologous pulmonary valve (APV) was implanted at the NPV position via left jugular vein catheterization. ICE and angiography were repeated to evaluate the position, morphology, function, and dimensions of the APV. An APV was successfully implanted in sheep J. In this paper, sheep J was selected to obtain representative results. A 30 mm APV with a Nitinol stent was accurately implanted at the NPV position without any significant hemodynamic change. There was no paravalvular leak, no new pulmonary valve insufficiency, or stented pulmonary valve migration. This study demonstrated the feasibility and safety, in a long-time follow-up, of developing an APV for implantation at the NPV position with a self-expandable Nitinol stent via jugular vein catheterization in an adult sheep model.
经导管肺动脉瓣置换术已被确立为右心室流出道或生物瓣功能障碍患者的可行替代方法,具有出色的早期和晚期临床结果。然而,对于终身应用,必须解决诸如支架心脏瓣膜恶化、冠状动脉闭塞、心内膜炎和其他并发症等临床挑战,特别是在儿科患者中。为了为患者开发终身解决方案,在成年绵羊模型中进行了经导管自体肺动脉瓣置换术。在全身麻醉通气下,通过左前外侧小开胸术从绵羊中采集自体心包。将心包置于 3D 成型心脏瓣膜模型上进行无毒交联 2 天 21 小时。进行心腔内超声心动图(ICE)和血管造影术以评估原生肺动脉瓣(NPV)的位置、形态、功能和尺寸。修剪后,交联的心包被缝合到自扩张的镍钛诺支架上,并压接成自行设计的输送系统。通过左颈静脉置管将自体肺动脉瓣(APV)植入 NPV 位置。重复进行 ICE 和血管造影术以评估 APV 的位置、形态、功能和尺寸。成功地在绵羊 J 中植入了 APV。本文选择绵羊 J 以获得代表性结果。将 30 毫米的 APV 与 Nitinol 支架准确地植入 NPV 位置,没有任何明显的血液动力学变化。没有瓣周漏、新的肺动脉瓣关闭不全或支架肺动脉瓣迁移。这项研究证明了在成年绵羊模型中通过颈静脉置管经导管肺动脉瓣置换术在 NPV 位置植入自扩张 Nitinol 支架的 APV 的可行性和安全性,并且进行了长时间的随访。